SER-130

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSER-130
Drug Alias NameSER-130SER-130-AMI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-4 receptor subunit alpha agonists
TargetsInterleukin-4 receptor subunit alpha
Therapy Area/IndicationsDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSerodus
China Registration ClassN/A

Develop Information

Active CompaniesSerodus
Inactive CompaniesN/A
Active IndicationsDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A